Eledon Pharmaceuticals Financial Overview
Eledon Pharmaceuticals's market cap is currently $117.88M. The company's EPS TTM is $-0.21; its P/E ratio is -1.33; Eledon Pharmaceuticals is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
